Skip to main content
Figure 2 | Journal of Cardiothoracic Surgery

Figure 2

From: VEGF attenuates development from cardiac hypertrophy to heart failure after aortic stenosis through mitochondrial mediated apoptosis and cardiomyocyte proliferation

Figure 2

Ad-VEGF treatment improves heart function at two weeks after viral delivery. A, Representative photographs of the hearts for sham, TAC, EGFP and VEGF mice B, Representative transthoracic M-mode echocardiogram for sham, TAC, EGFP and VEGF mice C, IVSd, LVPW, LVFS, ratios of heart weight to body weight and heart weight to tibia length data for sham, TAC, EGFP and VEGF mice. *P < 0.05, TAC vs. Sham; †P < 0.05, VEGF vs. TAC.

Back to article page

Journal of Cardiothoracic Surgery

ISSN: 1749-8090

Contact us